Fig. 8From: Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through the inhibition of pro-inflammatory enzymes and cytokinesEffects of calipteryxin and (3’S,4’S)-3’,4’-disenecioyloxy-3’,4’-dihydroseselin on the protein expression levels of the MAPKs p-JNK1, p-p38, p-ERK and p-Akt in time course experimentsBack to article page